Skip to content

Clinical trials

Phase 2 Lung Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 2 Country / region: Taiwan Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20101
20112
20123
20133
20141
20152
20171
20182
20201
20213
20224
20232
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting9
Active, not recruiting5
Terminated3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer5
Novartis Pharmaceuticals4
AstraZeneca3
Arcus Biosciences, Inc.2
Boehringer Ingelheim2
Apollomics Inc.1
Cathay General Hospital1
Daiichi Sankyo1
Eisai Inc.1
Far Eastern Memorial Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms33
Carcinoma, Non-Small-Cell Lung24
Adenocarcinoma of Lung5
Neoplasm Metastasis3
Neoplasms3
Pancreatic Neoplasms3
Urinary Bladder Neoplasms3
Carcinoma2
Lung Diseases2
Stomach Neoplasms2

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.